<unk> (2 dose) is a vaccine that is FDA approved for the prevention of invasive disease caused<unk> y Neisseria meningitidis serogroup<unk> .   Common adverse reactions include pain at the injection site (≥83%), myalgia (≥48%), erythema (≥45%), fatigue (≥35%), headache (≥33%), induration (≥ 28%), nausea (≥18%), and arthralgia (≥13%).
Meningococcal Group B Vaccine 
Meningitis vaccine
Ebola vaccines
Smallpox vaccine
Polio vaccine
Pneumococcal Vaccine 13-Valent
Caries vaccine
Malaria vaccine